E. Kedhi

发表

Complementary Pharmacotherapy for STEMI Undergoing Primary PCI: An Evidence-Based Clinical Approach

A. V. Van't Hof, E. Fabris, G. Sinagra, 2022, American Journal of Cardiovascular Drugs.

Impact of aging on the effects of intracoronary adenosine, peak hyperemia and its duration during fractional flow reserve assessment

H. Suryapranata, G. De Luca, M. Verdoia, 2021, Coronary artery disease.

Impact of SARS-CoV-2 positivity on clinical outcome among STEMI patients undergoing mechanical reperfusion: Insights from the ISACS STEMI COVID 19 registry

Massimo Siviglia, J. Mehilli, G. De Luca, 2021, Atherosclerosis.

Impact of age on the comparison between short-term vs 12-month dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: 2-Year follow-up results of the REDUCE trial.

H. Suryapranata, D. Dudek, G. De Luca, 2021, Atherosclerosis.

Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis

G. Stone, A. Kirtane, M. Leon, 2012, The Lancet.

Clinical outcomes according to lesion complexity in high bleeding risk patients treated with 1‐month dual antiplatelet therapy following PCI: Analysis from the Onyx ONE clear study

M. Price, G. Stone, S. Windecker, 2021, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Polymer Coating Integrity, Thrombogenicity and Computational Fluid Dynamics Analysis of Provisional Stenting Technique in the Left Main Bifurcation Setting: Insights from an In-Vitro Model

P. Gąsior, N. Foin, Shengjie Lu, 2022, Polymers.

Gender differences with short-term vs 12 months dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: 2-years follow-up results of the REDUCE trial

H. Suryapranata, G. De Luca, A. V. Van't Hof, 2021, Journal of Thrombosis and Thrombolysis.

Long-term outcomes following drug-eluting balloon or thin-strut drug-eluting stents for treatment of in-stent restenosis stratified by duration of dual antiplatelet therapy (DEB-Dragon Registry)

M. Jaguszewski, F. D’Ascenzo, R. Gil, 2022, Postepy w kardiologii interwencyjnej = Advances in interventional cardiology.

Impact of opioids on P2Y12 receptor inhibition in patients with ST-elevation myocardial infarction who are pre-treated with crushed ticagrelor: Opioids aNd crushed Ticagrelor In Myocardial infarction Evaluation (ON-TIME 3) trial

J. Ottervanger, O. Klungel, D. Angiolillo, 2020, European heart journal. Cardiovascular pharmacotherapy.

Short‐term dual antiplatelet therapy in diabetic patients admitted for acute coronary syndrome treated with a new‐generation drug‐eluting stent

H. Suryapranata, G. De Luca, M. Verdoia, 2022, Diabetes/metabolism research and reviews.

Coronary Stenting in Patients With Small Coronary Arteries at High Risk of Bleeding: Onyx ONE Clear

M. Price, G. Stone, T. Nazif, 2022, Journal of the Society for Cardiovascular Angiography & Interventions.

Percutaneous Coronary Intervention vs. Coronary Artery Bypass Grafting for Treating In-Stent Restenosis in Unprotected-Left Main: LM-DRAGON-Registry

D. Dudek, A. Lansky, M. Jaguszewski, 2022, Frontiers in Cardiovascular Medicine.

Long-Term Outcomes Following Drug-Eluting Balloons Versus Thin-Strut Drug-Eluting Stents for Treatment of In-Stent Restenosis (DEB-Dragon-Registry)

D. Dudek, M. Jaguszewski, F. D’Ascenzo, 2021, Circulation. Cardiovascular interventions.

IMPACT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE ON SHORT-TERM OUTCOME IN PATIENTS WITH ST-ELEVATION MYOCARDIAL INFARCTION DURING COVID-19 PANDEMIC: INSIGHTS FROM THE INTERNATIONAL MULTICENTER ISACS-STEMI REGISTRY

H. Suryapranata, G. De Luca, C. von Birgelen, 2022, Journal of the American College of Cardiology.

Complementary Pharmacotherapy for STEMI Undergoing Primary PCI: An Evidence-Based Clinical Approach

A. V. Van't Hof, E. Fabris, G. Sinagra, 2022, American Journal of Cardiovascular Drugs.

SARS-CoV-2 Positivity, Stent Thrombosis, and 30-day Mortality in STEMI Patients Undergoing Mechanical Reperfusion

H. Suryapranata, G. De Luca, C. von Birgelen, 2022, Angiology.

Intracoronary Imaging of Vulnerable Plaque—From Clinical Research to Everyday Practice

Elżbieta Pociask, T. Roleder, I. Jang, 2022, Journal of clinical medicine.

Are There Differences in the Demographics and Clinical Outcomes Between Asian and European Patients Treated With the COMBO Dual Therapy Stent in the REDUCE Trial Populations?

H. Suryapranata, G. De Luca, L. Barbieri, 2022, Journal of Asian Pacific Society of Cardiology.

Impact of Smoking Status on Mortality in STEMI Patients Undergoing Mechanical Reperfusion for STEMI: Insights from the ISACS–STEMI COVID-19 Registry

H. Suryapranata, G. De Luca, C. von Birgelen, 2022, Journal of clinical medicine.

Renin-angiotensin system inhibitors and mortality among diabetic patients with STEMI undergoing mechanical reperfusion during the COVID-19 pandemic

H. Suryapranata, G. De Luca, C. von Birgelen, 2021, Diabetes Epidemiology and Management.

Intra-coronary Imaging for the Evaluation of Plaque Modifications Induced by Drug Therapies for Secondary Prevention

C. Di Mario, E. Fabris, I. Kilic, 2020, Current Atherosclerosis Reports.

H. Suryapranata, G. De Luca, C. von Birgelen, 2022, Journal of the American College of Cardiology.

COVID-19 pandemic, mechanical reperfusion and 30-day mortality in ST elevation myocardial infarction

H. Suryapranata, G. De Luca, C. von Birgelen, 2021, Heart.

Impact of COVID-19 Pandemic on Mechanical Reperfusion for Patients With STEMI

Massimo Siviglia, J. Mehilli, D. Dudek, 2020, Journal of the American College of Cardiology.

Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis

G. Stone, A. Kirtane, M. Leon, 2012, The Lancet.

Revascularization in Ischemic Heart Failure with Reduced Left Ventricular Ejection Fraction

P. Gąsior, W. Wojakowski, E. Kedhi, 2023, Current Cardiology Reports.

Impact of renin-angiotensin system inhibitors on mortality during the COVID Pandemic among STEMI patients undergoing mechanical reperfusion: Insight from an international STEMI registry

G. De Luca, C. von Birgelen, G. Galasso, 2021, Biomedicine & Pharmacotherapy.

Thin-cap fibroatheroma predicts clinical events in diabetic patients with normal fractional flow reserve: the COMBINE OCT-FFR trial.

J. Granada, G. De Luca, C. von Birgelen, 2021, European heart journal.

Long-term outcomes of patients with normal fractional flow reserve and thin-cap fibroatheroma.

J. Granada, G. De Luca, C. von Birgelen, 2022, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Morphological characteristics of lesions with thin cap fibroatheroma-a substudy from the COMBINE (OCT-FFR) trial.

J. Granada, G. De Luca, C. von Birgelen, 2022, European heart journal. Cardiovascular Imaging.

Thin-Cap Fibroatheroma Rather Than Any Lipid Plaques Increases the Risk of Cardiovascular Events in Diabetic Patients: Insights From the COMBINE OCT–FFR Trial

J. Granada, G. De Luca, C. von Birgelen, 2022, Circulation. Cardiovascular interventions.

Dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk: a meta-analysis of randomized trials.

Deepak L. Bhatt, G. Stone, S. Windecker, 2022, European heart journal.

Current Role of Intracoronary Imaging for Implementing Risk Stratification and Tailoring Culprit Lesion Treatment: A Narrative Review

G. De Luca, G. Guagliumi, M. Verdoia, 2023, Journal of clinical medicine.

H. Suryapranata, G. De Luca, C. von Birgelen, 2023, Journal of Clinical Medicine.

Gender Difference in the Effects of COVID-19 Pandemic on Mechanical Reperfusion and 30-Day Mortality for STEMI: Results of the ISACS-STEMI COVID-19 Registry

H. Suryapranata, G. De Luca, C. von Birgelen, 2023, Journal of clinical medicine.

Polymer-Based Versus Polymer-Free Stents in High Bleeding Risk Patients: Final 2-Year Results From Onyx ONE.

M. Price, G. Stone, Z. Ali, 2022, JACC. Cardiovascular interventions.

Intravascular imaging beyond ischaemia assessment: a possible way for improving risk stratification.

E. Fabris, G. Sinagra, E. Kedhi, 2021, European heart journal. Cardiovascular Imaging.

Exploring new insights in coronary lesion assessment and treatment in patients with diabetes mellitus: the impact of optical coherence tomography

R. Hermanides, E. Fabris, E. Kedhi, 2023, Cardiovascular Diabetology.

H. Suryapranata, G. De Luca, C. von Birgelen, 2023, Journal of clinical medicine.

Current Management of Highly Calcified Coronary Lesions: An Overview of the Current Status

C. Di Mario, G. De Luca, G. Caiazzo, 2023, Journal of clinical medicine.

Platelets and the Atherosclerotic Process: An Overview of New Markers of Platelet Activation and Reactivity, and Their Implications in Primary and Secondary Prevention

G. Galasso, M. Verdoia, M. Nardin, 2023, Journal of clinical medicine.

Impact of chronic obstructive pulmonary disease on short-term outcome in patients with ST-elevation myocardial infarction during COVID-19 pandemic: insights from the international multicenter ISACS-STEMI registry

H. Suryapranata, G. De Luca, C. von Birgelen, 2022, Respiratory Research.

Fractional Flow Reserve-Negative High-Risk Plaques and Clinical Outcomes After Myocardial Infarction.

P. Damman, R. Oemrawsingh, M. Meuwissen, 2023, JAMA cardiology.

Sex Differences in Revascularization, Treatment Goals, and Outcomes of Patients With Chronic Coronary Disease: Insights From the ISCHEMIA Trial

J. Spertus, H. Suryapranata, A. Bagai, 2024, Journal of the American Heart Association.

Vitamin D and Cardiovascular Diseases: From Physiology to Pathophysiology and Outcomes

G. Galasso, M. Verdoia, M. Nardin, 2024, Biomedicines.

Medically Treated Nonischemic Thin-Cap Fibroatheroma Lesions Versus Fractional Flow Reserve-Guided Complete Revascularization in Diabetic Patients

R. Oemrawsingh, R. Hermanides, B. Berta, 2023, Journal of the Society for Cardiovascular Angiography & Interventions.

FINAL TWO-YEAR RESULTS FROM THE RANDOMIZED ONYX ONE TRIAL IN HIGH BLEEDING RISK PATIENTS TREATED WITH 1-MONTH DAPT

M. Price, G. Stone, A. Kirtane, 2021 .

Vulnerable plaque features and adverse events in patients with diabetes mellitus: a post hoc analysis of the COMBINE OCT-FFR trial.

R. Hermanides, J. Cuesta, B. Berta, 2024, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.